In last trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 0.61 million shares changing hands with its beta currently measuring 2.12. Company’s recent per share price level of $9.17 trading at -$0.5 or -5.17% at ring of the bell on the day assigns it a market valuation of $51.26M. That closing price of TNXP’s stock is at a discount of -13474.7% from its 52-week high price of $1244.80 and is indicating a discount of -2.51% from its 52-week low price of $9.40.
For Tonix Pharmaceuticals Holding Corp (TNXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -768 in the current quarter.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Upright in the red during last session for losing -5.17%, in the last five days TNXP remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $9.17 price level, adding 23.65% to its value on the day. Tonix Pharmaceuticals Holding Corp’s shares saw a change of -72.20% in year-to-date performance and have moved -19.77% in past 5-day. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) showed a performance of -71.25% in past 30-days.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
This year revenue growth is estimated to rise 64.78% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.2M for the same. And 1 analysts are in estimates of company making revenue of 4.2M in the next quarter. Company posted 3.78M and 2.48M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 79.31% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 95.88% while estimates for its earnings growth in next 5 years are of 78.59%.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 10.45 shares of worth $95826.0 or 0.19% of the total outstanding shares. The later fund manager was in possession of 4.03 shares on Dec 31, 2024 , making its stake of worth around $36982.0 in the company or a holder of 0.07% of company’s stock.
